Bladder Cancer Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working

Urine is stored in the bladder, which is a hollow organ in the lower abdomen. Bladder cancer develops in the bladder's lining. Transitional cell carcinoma, commonly known as urothelial carcinoma, is the most frequent type of bladder cancer. Smoking is one of the leading causes of bladder cancer. Bladder cancer is frequently detected in its early stages.

Bladder cancer was rated 10th among all cancers in the globe, with 549,000 new cases and 200,000 deaths each year; it contributed 3.4 percent to the overall cancer burden worldwide. There were 18,921 new cases and 10,231 deaths in India.

DelveInsight’s “Bladder Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bladder Cancer, historical and forecasted epidemiology as well as the Bladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Bladder Cancer Market Report:

  •  An Estimated 573,278 people were diagnosed with Bladder Cancer WorldWide in 2020

  •  Bladder Cancer is the fourth most common cancer among the men

  • There has been a decline of 1%/year in the number of cases of Bladder Cancer in the US from 2009-to 2018 

  • Bladder cancer was rated 10th among all cancers in the globe, with 549,000 new cases and 200,000 deaths each year 

  • While the specific aetiology of bladder cancer is unknown, it has been related to a number of risk factors, including tobacco use and exposure to certain chemicals and gases. In addition, persons who have a family history of bladder cancer are more likely to get the disease

Got queries? Click here to know more about the Bladder Cancer Market Landscape

Bladder Cancer Symptoms: 

  • Blood in the Urine can be seen

  • Pain is felt while urinating

  • Back Pain

  • Pain in The Pelvic area

Bladder Cancer Market: 

The dynamics of the Bladder Cancer market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as and others during the forecasted period 2018-2030. 

The key players working in the field of Bladder Cancer are the - Swiss Group for Clinical Cancer Research, University of Kansas Medical Center, University of Oklahoma, Radiation Therapy Oncology Group, National Cancer Institute (NCI), and ImmunityBio, Inc. 

Learn more by requesting for sample @ Bladder Cancer Market Landscape 

Bladder Cancer Pipeline Therapies:

  •  VPM1002BC

  • Ascorbic Acid

  • Avelumab

  • Cisplatin

  •  Paclitaxel

  • Mitomycin C

  • N-803 and BCG 

Bladder Cancer and Key Companies: 

  • Swiss Group for Clinical Cancer Research

  • University of Kansas Medical Center

  • University of Oklahoma

  • Radiation Therapy Oncology Group

  • National Cancer Institute (NCI)

  • ImmunityBio, Inc. 

Click here to read more about Bladder Cancer Market Outlook 2032

Related Reports: 

Bladder Cancer Pipeline 

 "Bladder Cancer Pipeline Insight, 2021" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Bladder Cancer market. A detailed picture of the Bladder Cancer pipeline landscape is provided, which includes the disease overview and Bladder Cancer treatment guidelines. 

Bladder Cancer Epidemiology 

DelveInsight's 'Bladder Cancer  Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Bladder Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports By Delveinsight:

Comments

Post a Comment

Popular posts from this blog

The Great PD-1 Inhibitor Battle: OPDIVO vs. KEYTRUDA in Japan

Image
  Analyzing OPDIVO’s Pre-2022 Sales Decline and KEYTRUDA’s Market Ascendancy Before 2022, OPDIVO, developed by Bristol-Myers Squibb (BMS), faced a significant sales decline in Japan’s PD-1 inhibitor market. Despite its initial success, the PD-1 and PD-L1 inhibitors faced challenges from new competitors and evolving market dynamics. One key competitor was Merck's KEYTRUDA, which steadily gained market share due to its broader range of approved indications and successful clinical trial outcomes. KEYTRUDA’s market ascendancy was marked by its approval for various cancers, including melanoma, non-small cell lung cancer, and urothelial carcinoma, among others, making it a versatile choice for oncologists. How OPDIVO Outpaced KEYTRUDA in Japan’s Pharmaceutical Market In 2022, OPDIVO made a remarkable comeback, outpacing KEYTRUDA in Japan’s pharmaceutical market. This resurgence was driven by several strategic moves by BMS. The company expanded OPDIVO’s indications, securing approvals fo
Read more

A detailed analysis of Vascular Stents Market Trends, Growth Opportunities, Challenges, and Epidemiology Forecast

Image
A vascular surgeon places a stent, which is a hollow mesh tube that supports the blood vessel's walls permanently and prevents it from closing up again (restenosis). Some stents are drug-eluting, which means they release medicine over time to help prevent another blockage. The  Vascular Stents market is being driven by a growing geriatric population as well as an increase in the number of surgical operations. The  Vascular Stents Market report from DelveInsight provides an in-depth analysis of  Vascular Stents, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some Key Highlights from the  Vascular Stents Market Report The artery is kept open by a stent, which is a small metal mesh tube. The two methods for opening clogged peripheral arteries are angioplasty and stent implantation. Vascular Stents market is segmented on the basis of Product type, By Applications and End-user. Some of the
Read more
Image
Obstructive Sleep Apnea Market Trends and Therapeutic Advancements !! Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.  Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory problems, headach
Read more